Is prostate cancer a Lynch syndrome cancer?

Asian Journal of Andrology

Volumn 15, Issue 5, 2013, Pages 588-589

  Win, Aung Ko ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; ENDOMETRIUM CANCER; FAMILY HISTORY; GENE MUTATION; GENOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; HETEROZYGOTE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84883475375     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2013.87     Document Type: Article

References (20)

1. Jass Jr. Hereditary Non-Polyposis Colorectal Cancer: The rise and fall of a confusing term. World J Gastroenterol 2006; 12: 4943-50
2. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8
3. Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM et al. Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 2013; 31: 1713-8
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917
5. Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996; 144: 1041-7
6. Leongamornlert D, Mahmud N, Tymrakiewicz M, Saunders E, Dadaev T et al. Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer 2012; 106: 1697-701
7. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91: 1310-6
8. Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E et al. BRCA2 is a moderate penetrance gene contributing to youngonset prostate cancer: Implications for genetic testing in prostate cancer patients. Br J Cancer 2011; 105: 1230-4
9. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 2012; 366: 141-9
10. Xu J, Lange EM, Lu L, Zheng SL,Wang Z et al. HOXB13 is a susceptibility gene for prostate cancer: Results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2013; 132: 5-14
11. Soravia C, van der Klift H, Bründler MA, Blouin JL, Wijnen J et al. Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum. Am J Med Genet A. 2003; 121A: 159-62
12. Wagner DG, Gatalica Z, Lynch HT, Kohl S, Johansson SL et al. Neuroendocrine-Type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome. Int J Surg Pathol 2010; 18: 550-3
13. Bauer C, Ray A, Halstead-Nussloch B, Dekker R, Raymond V et al. Hereditary prostate cancer as a feature of Lynch Syndrome. Fam Cancer 2011; 10: 37-42
14. Buttin BM, Powell MA, Mutch DG, Babb SA, Huettner PC et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004; 74: 1262-9
15. Grindedal EM, Moller P, Eeles R, Stormorken AT, Bowitz-Lothe IM et al. Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 2460-7
16. Win AK, Lindor N, Jenkins M. Risk of breast cancer in Lynch syndrome: A systematic review. Breast Cancer Res 2013; 15: R27
17. Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013; 34: 490-7
18. Win AK, Young JP, Lindor NM, Tucker K, Ahnen D et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol 2012; 30: 958-64
19. Win AK, Lindor NM, Young JP, Macrae FA, Young GP et al. Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst 2012; 104: 1363-72
20. Park JG, Park YJ, Wijnen JT, Vasen HF. Geneenvironment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. Int J Cancer 1999; 82: 516-9